Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Calls For Class-Wide REMS For LABA Asthma Drugs

Feb 18 2010

• By The Pink Sheet Daily

Related Content

FDA Panels Favor Advair, Symbicort Over Single-Entity LABA Products For Asthma

Dec 11 2008

Asthma Trial Design To Be Focus Of Advisory Committee

Feb 02 2010

ESA REMS Allows Oncology Providers One Year To Enroll Before Possible Distribution Limits

Feb 16 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window